Loading the map…
General medical practice activities · London
Mirmin
Mirmin Limited
Private limited company registered in London, classed under “General medical practice activities”.
Headline figures
FY to Sept 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
What the numbers say
1 finding from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2023 | 2024 | 2025 |
|---|---|---|---|
| Profit after tax | — | ||
| Turnover | |||
| Net assets | |||
| Cash | |||
| Employees |
Every figure for all 3 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current assets | |||
| Creditors due within a year | |||
| Net current assets | |||
| Net assets | |||
| Ratios | |||
| Current ratioCurrent assets for every £1 owed within a year | |||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | |||
4 balance-sheet lines and 2 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Mirmin do?
Private limited company registered in London, classed under “General medical practice activities”.
›How much turnover does Mirmin make?
Answered in the full report
›Is Mirmin profitable?
Mirmin's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Mirmin?
Answered in the full report
›Where is Mirmin based?
Its registered office is The Brenatano Suite Solar House, 915 High Road, North Finchley, London, N12 8QJ, in London.
›When was Mirmin founded?
Mirmin Limited was incorporated on 26 September 2022.
›Is Mirmin still trading?
The register lists Mirmin Limited as active.